Fish farming companies account for more than 80% demand of autogenous vaccines for aquaculture


Fish is a widely consumed food across the world

The global autogenous vaccine for aquaculture market is expected to witness a CAGR of 5.5% during the forecast period (2020-2030). (Image source: Adobe Stock)

In 2019, 177.8 mmt of fish were produced globally. Despite such huge production in aquaculture, the bacterial disease is a major issue, and is causing multibillion-dollar losses annually. In developing countries, fish diseases often spread quickly between small-scale aquaculture farms. Rising prevalence of infectious diseases such as bacterial diseases, viral diseases, and parasitic and fungal diseases amongst fish species remains a global issue for fish farmers.

Autogenous vaccines have been playing a vital role in bacterial disease control in aquaculture. This is the most effective method for preventing a wide range of bacterial and viral diseases. Autogenous vaccines are widely accepted by aquaculture farming companies during emergency outbreaks, due to very few commercial vaccines being available for specific aquaculture-related diseases.

According to the latest report published by Persistence Market Research, the global autogenous vaccine for aquaculture market was valued at US$11mn in 2020, and is expected to witness a CAGR of 5.5% during the forecast period (2020-2030).

Key takeaways from autogenous vaccine for aquaculture market study

-The salmon fish species is expected to contribute more than 40% revenue share to the market.

-By pathogen type, bacteria held the highest market share in 2019, due to bacterial infections being more frequent across fish farms.

North America and Europe collectively account for nearly one-third share in the global autogenous vaccine for aquaculture market.

-Leading players are focused on improving their services, and have established collaborations with fish farming companies to provide customised products.

Fish farming companies are expected to hold a prominent share in the market, owing to high adoption of autogenous vaccine services at these facilities.

-The COVID-19 outbreak has had a negative impact on the global autogenous vaccine for aquaculture market, mainly due to export restrictions.

-This industry has expanded at around 4% over the last 5 years, but growth is projected to increase to around 5.5% CAGR through 2030.

-The United States accounts for around 20% of global demand.

-Norway holds more than one-third of the share in Europe, which is the largest regional market for autogenous vaccines for aquaculture.

African Farming

Share your story with us: +2348135229228 (call and SMS only) Email: [email protected], Complain about a story or Report an error and/or correction: +2348135229228 DISCLAIMER: Comments on this thread are that of the maker and they do not necessarily reflect the organization's stand or views on issues.


Please enter your comment!
Please enter your name here